Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03704480
Title Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy (IMMUNO-BIL)
Acronym IMMUNO-BIL
Recruitment Active, not recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors GERCOR - Multidisciplinary Oncology Cooperative Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHRU Jean Minjoz Besançon France Details
Polyclinique Bordeaux Nord Aquitaine Bordeaux France Details
Hôpital Duchenne Boulogne-sur-Mer France Details
CHU Morvan Brest France Details
Hôpital Beaujon Clichy France Details
CHPSO Site de Creil Creil France Details
CHU Henri Mondor Créteil France Details
Centre Georges François Leclerc Dijon France Details
CHU Dijon Dijon France Details
Institut Andrée Dutreix Dunkerque France Details
Institut Hospitalier franco-Britannique Levallois-Perret France Details
CHRU Lille Lille France Details
Centre Léon Bérard Lyon France Details
Hôpital Privé Jean Mermoz Lyon France Details
Hôpital la Timone Marseille France Details
Hôpital Saint Eloi Montpellier France Details
Hôpital Prive du confluent SAS Nantes France Details
Hôpital Cochin Paris France Details
Hôpital Saint Antoine Paris France Details
Institut Mutualiste Montsouris Paris France Details
Hôpital Haut Lévêque Pessac France Details
CHU Poitiers Poitiers France Details
CHU Robert Debré Reims France Details
Centre Eugène Marquis Rennes France Details
Institut Curie Saint Cloud France Details
CHI Poissy Saint Germain Saint-Germain-en-Laye France Details
Centre Paul Strauss Strasbourg France Details
Insitut Gustave Roussy Villejuif France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field